Search Results - "Gobitti, Carlo"

Refine Results
  1. 1

    Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance by Muraro, Elena, Fanetti, Giuseppe, Lupato, Valentina, Giacomarra, Vittorio, Steffan, Agostino, Gobitti, Carlo, Vaccher, Emanuela, Franchin, Giovanni

    Published in Critical reviews in oncology/hematology (01-08-2021)
    “…Cellular and immune mechanisms involved in cetuximab activities and effects. (A) Cetuximab mechanism of action. Schematic model of the main mechanisms of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy by Polesel, Jerry, Furlan, Carlo, Birri, Silvia, Giacomarra, Vittorio, Vaccher, Emanuela, Grando, Giuseppe, Gobitti, Carlo, Navarria, Federico, Schioppa, Ornella, Minatel, Emilio, Bidoli, Ettore, Barzan, Luigi, Franchin, Giovanni

    Published in Oral oncology (01-04-2017)
    “…Highlights • Treatment delay is associated to a worse prognosis in head & neck cancer patients. • Treatment initiation within 45 days from diagnosis is…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy by Bortolin, Maria Teresa, Tedeschi, Rosamaria, Bidoli, Ettore, Furlan, Carlo, Basaglia, Giancarlo, Minatel, Emilio, Gobitti, Carlo, Franchin, Giovanni, Trovò, Marco, De Paoli, Paolo

    Published in Biomarkers (03-10-2015)
    “…Objective: To evaluate whether plasma cell-free DNA (cfDNA) was related to clinical outcome in inoperable stage I non-small cell lung cancer (NSCLC) patients…”
    Get full text
    Journal Article
  8. 8

    Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer by Vaccher, Emanuela, Schioppa, Ornella, Martellotta, Ferdinando, Fornasier, Giulia, Giacomin, Elisa, Re, Francesco Lo, Baldo, Paolo, Corona, Giuseppe, Gobitti, Carlo

    “…Thyroid cancer is the most common endocrine neoplasia and represents approximately 1.5% to 2.1% of all cancers diagnosed annually worldwide. Iodine Refractory…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis by Franchin, G, Minatel, E, Gobitti, C, Talamini, R, Sartor, G, Caruso, G, Grando, G, Politi, D, Gigante, M, Toffoli, G, Trovò, M G, Barzan, L

    “…At least in some European Countries, there is still considerable controversy regarding the choice between surgery and radiotherapy for the treatment of…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Correction to: Unusual presentation of recurrent papillary thyroid microcarcinoma with neck muscles and skin dissemination by Sindoni, Alessandro, Gobitti, Carlo, Sulfaro, Sandro, Giacomarra, Vittorio, Borsatti, Eugenio

    Published in Hormones (Athens, Greece) (01-12-2018)
    “…The original version of this article unfortunately contained a mistake. The title of this article was rendered incorrectly; the correct title is as follows:…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Malignant struma ovarii harboring a unique NRAS mutation: case report and review of the literature by Gobitti, Carlo, Sindoni, Alessandro, Bampo, Chiara, Baresic, Tanja, Giorda, Giorgio, Alessandrini, Lara, Canzonieri, Vincenzo, Franchin, Giovanni, Borsatti, Eugenio

    Published in Hormones (Athens, Greece) (01-07-2017)
    “…Struma ovarii (SO), a rare tumor containing at least 50% of thyroid tissue, represents approximately 5% of all ovarian teratomas; its malignant transformation…”
    Get full text
    Journal Article
  20. 20